Today: 2 July 2026
Deere & Company stock price at $662: earnings pop fades, tariffs and targets take over next week
21 February 2026
1 min read

Deere & Company stock price at $662: earnings pop fades, tariffs and targets take over next week

New York, Feb 21, 2026, 14:56 EST — Market closed.

  • Deere finished Friday at $662.49, ticking up 0.07%.
  • Deere shares jumped almost 12% as the company boosted its full-year earnings forecast, following a strong quarterly performance.
  • Coming up: Deere will hold its virtual annual meeting on Feb. 25, starting at 10 a.m. CST.

Deere & Co ended Friday at $662.49, ticking up 0.49. That caps a two-day gain of roughly 11.6% after Thursday’s earnings-fueled surge. U.S. markets next open Monday.

Moline, Illinois-based tractor and construction equipment manufacturer lifted its fiscal 2026 net income target to a range between $4.5 billion and $5.0 billion, pointing to stronger order books and shipments outpacing expectations. CEO John May described 2026 as “the bottom of the current cycle.” PR Newswire

Deere has been cutting production and teaming up with dealers to keep machinery inventories tight as farmers delay major buys—a strategy that stands out now. Analyst Kristen Owen at Oppenheimer pointed out that Deere wrapped up the quarter with “relatively lean inventories.” The company also signaled a pre-tax tariff impact nearing $1.2 billion for fiscal 2026. Reuters

Deere turned in first-quarter earnings of $656 million, or $2.42 a share—down from a year ago, but still ahead of forecasts. Revenue climbed 13% to $9.61 billion. Construction and forestry net sales surged 34%, small agriculture and turf were up 24%. The company stuck to its outlook for production and precision agriculture sales, guiding for a 5% to 10% drop.

Deere on Thursday filed both its earnings release and an investor presentation for the quarter. Those documents often influence how investors weigh changes in pricing, costs, and orders—not just the upgraded guidance.

Deere shares saw action in a range from $646.40 up to $666.92 on Friday, with about 3 million shares changing hands, Yahoo Finance data showed. The stock barely budged, and most traders appeared content to hold rather than pile in on the uptick.

Stocks pushed up on Friday as the U.S. Supreme Court tossed out President Donald Trump’s global tariffs. Still, Trump announced a 10% temporary levy for 150 days. Uncertainty over trade costs lingers for industrials as the new week approaches.

Deere, though, isn’t out of the woods on large ag equipment yet—farmer spending usually moves with crop prices and interest rates. Barron’s flagged weak crop prices as a serious risk, despite upbeat sentiment following Deere’s earnings that spilled over to AGCO and CNH Industrial shares.

Following the results, analysts wasted no time. Wells Fargo, UBS, Truist, and DA Davidson all bumped up their price targets for Deere on Friday, MT Newswires reported.

Feb. 25 is up next: Deere’s annual shareholder meeting kicks off at 10 a.m. CST. Investors are expected to zero in on tariffs, inventory levels, and what’s ahead for big ag equipment. Deere will also be heading to Las Vegas for CONEXPO-CON/AGG, running March 3-7—an event that tends to put a spotlight on its construction segment.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Emerging Growth Research Keeps Buy on OSR Health, Notes New Shareholder Loyalty Program
    July 2, 2026, 2:21 PM EDT. Emerging Growth Research is sticking with its Buy-Emerging rating on OSR Health (Nasdaq:OSRH) and keeps its $10 price target. Analysts point to a new Shareholder Loyalty Program that issues Contingent Value Rights (CVRs), offering holders more shares if OSRH stock hits set price marks in the next year. The tiered reward system could give investors up to six times their original shares, and management says it's an alternative to a reverse split. The plan targets better liquidity, aims to keep short sellers away, and looks to reward long-term holders. This comes after OSRH signed a $815 million BCM Europe licensing deal, with the company still working on new drug candidates and wearable health tech that back hopes for stock price gains.
Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Previous Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop